Bulletin
Investor Alert

Market Pulse Archives

Aug. 3, 2020, 7:56 a.m. EDT

AbbVie, Amgen and Takeda start testing drugs as COVID-19 treatments

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    AbbVie Inc. (ABBV)
  • X
    Amgen Inc. (AMGN)
  • X
    Takeda Pharmaceutical Co. Ltd. ADR (TAK)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.37% , Amgen Inc. /zigman2/quotes/209157011/composite AMGN +1.46% , and Takeda Pharmaceutical Co. Ltd. /zigman2/quotes/204098703/composite TAK 0.00% announced they started enrolling patients in a clinical trial testing three of their drugs as treatments for severely ill and hospitalized COVID-19 patients. This includes the still investigational HIV therapy cenicriviroc, psoriasis medication Otezla, and the anti-inflammatory drug Firazyr. The companies are using a platform aimed at minimizing the number of clinical-trial participants and the time it takes to test those drugs under an umbrella group called the COVID R&D Alliance. Since the start of the year, AbbVie's stock is up 7.2%, shares of Amgen have gained 1.5%, and Takeda's stock is down 7.4%. The S&P 500 /zigman2/quotes/210599714/realtime SPX +1.60% is up 1.2%.

/zigman2/quotes/202428675/composite
US : U.S.: NYSE
$ 86.23
+0.32 +0.37%
Volume: 9.94M
Sept. 25, 2020 4:02p
P/E Ratio
18.34
Dividend Yield
5.47%
Market Cap
$152.18 billion
Rev. per Employee
$1.09M
loading...
/zigman2/quotes/209157011/composite
US : U.S.: Nasdaq
$ 243.82
+3.50 +1.46%
Volume: 2.64M
Sept. 25, 2020 4:00p
P/E Ratio
19.93
Dividend Yield
2.62%
Market Cap
$142.80 billion
Rev. per Employee
$1.11M
loading...
/zigman2/quotes/204098703/composite
US : U.S.: NYSE
$ 18.53
0.00 0.00%
Volume: 968,017
Sept. 25, 2020 4:00p
P/E Ratio
58.77
Dividend Yield
3.44%
Market Cap
$58.08 billion
Rev. per Employee
$591,848
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,298.46
+51.87 +1.60%
Volume: 2.18B
Sept. 25, 2020 5:06p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.